Patents by Inventor Ulrich Herrlinger

Ulrich Herrlinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROGLIAL PRECURSOR CELLS FOR THE TREATMENT OF MALIGNANT NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM
    Publication number: 20120183509
    Abstract: Microglial precursor cells for use in the treatment of malignant neoplasms of the central nervous system. A method of treating malignant neoplasms of the central nervous system comprising administering a pharmaceutically effective amount of microglial precursor cells to a subject in need thereof.
    Type: Application
    Filed: April 28, 2010
    Publication date: July 19, 2012
    Inventors: Harald Neumann, Martin Glas, Ruslan Masgutov, Ulrich Herrlinger, Kristian Welle
  • Neural stem cells and use thereof for brain tumor therapy
    Patent number: 7655224
    Abstract: The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: February 2, 2010
    Assignees: Children's Medical Center Corp., The General Hospital Corp., Northeastern Ohio Universities COM
    Inventors: Evan Y. Snyder, Xandra O. Breakefield, Karen S. Aboody, Ulrich Herrlinger, William P. Lynch
  • Neural stem cells and use thereof for brain tumor therapy
    Patent number: 7186409
    Abstract: The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: March 6, 2007
    Assignees: The Children's Medical Center Corporation, The General Hospital Corporation, Northeastern Ohio Universities College of Medicine
    Inventors: Evan Y. Snyder, Xandra O. Breakefield, Karen S. Aboody, Ulrich Herrlinger, William P. Lynch
  • Neural stem cells and use thereof for brain tumor therapy
    Publication number: 20070031391
    Abstract: The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 12, 2006
    Publication date: February 8, 2007
    Applicants: Children's Medical Center Corporation, The General Hospital Corporation, Northeastern Ohio Universities College of Medicine
    Inventors: Evan Snyder, Xandra Breakefield, Karen Aboody, Ulrich Herrlinger, William Lynch
  • Neural stem cells and use thereof for brain tumor therapy
    Publication number: 20020045261
    Abstract: The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 28, 2001
    Publication date: April 18, 2002
    Inventors: Evan Y. Snyder, Xandra O. Breakefield, Karen S. Aboody, Ulrich Herrlinger, William P. Lynch